Executives at Delisted Vicarious Surgical Cut Base Salaries
RBOT is trading near its 52-week low of $0.27 (0.0% above the low) on elevated volume (2.1× avg).
Summary
Vicarious Surgical's President, Adams Sachs, and Chief Technology Officer, Sammy Khalifa, have voluntarily reduced their annual base salaries. This move, effective March 4, 2026, signals a significant cost-cutting effort by the company's leadership. The decision comes shortly after the company was notified of its immediate trading suspension and delisting from the NYSE on March 4th, highlighting severe financial distress. For a company with a market cap of only $6.5 million and trading near its 52-week low, these salary reductions underscore the challenging financial environment and management's attempt to conserve cash. Investors will be closely watching for further strategic actions or disclosures regarding the company's path forward post-delisting.
At the time of this announcement, RBOT was trading at $0.27 on OTC in the Life Sciences sector, with a market capitalization of approximately $6.5M. The 52-week trading range was $0.27 to $13.75. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.